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A lopecia areata is a type of patchy baldness affecting both sexes and all ages that may become stable, regress to normal, or progress to total loss of scalp or all body hair [1]. The cause of this condition is uncertain, but it is generally believed to be an 
autoimmune disease [1]. Greater understandiug of the pathogenesis 
of this poorly controlled condition should lead to the development 
of better treatments; therefore, we are investigating alopecia areata 
using three approaches. These include immunohistologic and ul­
trastructural examination of clinically normal areas of alopecia 
areata scalps, investigation of circulating factors in patient blood, 
and analysis of the properties of cultured dermal papilla cells 
derived from alopecia areata follicles. 
Our initial studies showed that there was a definite lymphocytic 
infiltrate around follicles from unaffected regions of alopecia areata 
scalps with raised numbers of T 4-positive (i.e., helper) cells com­
pared to Ts-positive (suppresser) cells [2]. There was also a 
noticeable loss of the normal regular arrangement of dermal papilla 
cells [2] suggesting that a sub-clinical condition was often present in 
apparently unaffected areas of scalps from alopecia areata patients. 
These "clinically normal" follicles thus appear to offer the oppor­
tunity to investigate the earliest changes in the hair follicle and, 
therefore, hopefully help elucidate the etiology of the disease. 
Because the dermal papilla and its cells are known to play important 
regulatory roles in the hair follicle including determining the type 
of hair produced [3], and may be the site of androgen action and 
thus involved in androgen-dependent, male-pattern baldness [4], 
the ultrastructure of the dermal papilla of clinically normal follicles 
from alopecia areata scalps was compared to those of normal scalp 
and lesional alopecia areata follicles. 
Both types of alopecia areata follicles showed changes, with 
lesional follicles exhibiting the most marked abnormalities and the 
extent of the abnormality varying in clinically normal follicles. In 
the latter, reticular fibrous bands were present below the upper part 
of dermal papilla-epithelial junction and signs of cell injury were 
seen in dermal papilla cells, including a less fibroblastic shape, 
distorted nuclei, and cytoplasmic lucent spaces and pigmentary 
granules.:\: Therefore, in follicles where damage was not yet 
apparent externally the dermal papilla cells were already abnormal 
and the basement membrane thickened, implying that the dermal 
papilla was involved very early in the disease. However, changes 
were also detected amongst the melanocytes and outer root sheath 
cells of these follicles as discussed elsewhere at this meeting. § It is 
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not clear from these studies which is the primary site of damage; 
presumably reduction in the synthetic capability of dermal papilla 
cells or reduced ability of mitogenic factors to cross the membrane 
would inhibit normal follicular growth. Melanocytes, with their 
large surface area and delicate nature, may well be the first cells to 
be affected. The dermal papilla has been previously considered a 
primary target by earlier workers because of histologic changes in 
alopecia follicles [5]. 
If alopecia areata is an autoimmune disease then circulating 
autoantibodies or autoreactive T cells to hair follicular components 
would be expected. Therefore, serial vertical frozen sections from 
the edges of active alopecic lesions or normal scalp were incubated 
with either phosphate-buffered saline, to detect any antibodies 
deposited in vivo, or the patient's own serum to identify any 
circulating antibodies, followed by a pan-Ig fluorescentIy labeled 
antibody that detects all classes of immunoglobulins. Normal scalp 
only fluoresced in small areas correspondiug to the microvascula­
ture, but in most patient biopsies both with and witIlout serum the 
hair follicular epitIlelium, particularly the outer root sheath, fluo­
resced markedly; other epithelial structures, including the basal 
layers of the epidermis and sebaceous gland, were also highlight­
ed.,-r Patient serum also bound to these components in normal scalp 
sections.,-r This suggests that most patients contained autoantibodies 
to normal follicular and epidermal keratinocytes, rather than to 
some abnormality in the alopecia patients. Interestingly, autoanti­
bodies to keratinocytes have been recently reported by Duvic et aI, 
Tobin et ai, and Oliver et al (discussed elsewhere in these proceed­
ings). 
The role of these autoantibodies in tIle pathogenesis of alopecia 
areata is not clear; autoantibodies to normal follicular constituents 
could play an etiologic role by attacking normal follicles, but may 
be secondary features produced when normally isolated cells from 
damaged follicles enter the blood. Because dermal papilla cells 
derived from several species retain many characteristics reflecting 
their in vivo origin [3,4], examination of these cells may prove 
useful. Despite the absence of fluorescence in the dermal papilla, 
serum from patients with alopecia areata significantly inhibited the 
growth of normal dermal papilla cells (five cell lines) implicating a 
serum factor reacting to dermal papilla cells. ** 
Dermal papilla cells from the edges of active lesions of alopecia 
areata patients' scalp grew more slowly in culture and were not as 
able to withstand serum-free medium as normal cells. Conditioned 
mali ties in the ultrastructure of melanocytes and the outer root sheath of 
clinically normal hair follicles from alopecia areata scalps. ] Invest De,.malol 
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medium, i.e., that in which confluent dermal papilla cells had been 
grown for 48 h, was tested for growth-promoting activity on a 
human skin keratinocyte cell line using an MTT assay. Normal 
dermal papilla cell medium stimulated keratinocyte growth signif­
icandy at low concentrations compared to control non-conditioned 
medium but alopecia areata cell medium had no effect. This 
suggests that dermal papilla cells from normal follicles secrete 
soluble mitogenic factors that are not produced by alopecia areata 
cells. TIllS obviously merits further investigation as the absence of 
such mitogenic factors could be involved in the altered keratinocyte 
activity in the alopecia areata hair follicle. 
Overall, there are a number of aspects that implicate the dermal 
papilla in the pathogenesis of alopecia areata. Although it seems 
likely that the dermal papilla plays a key role at an early stage in the 
disease, it is not yet clear whether this is an etiologic role or part of 
the follicle's defense responses to an insult elsewhere in the follicle 
such as the melanocytes or follicular keratinocytes . 
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Immunologic Cytotoxicity in Alopecia Areata: 
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APOPTOSIS IN IMMUNOLOGIC CYTOTOXICITY 
Apoptosis is an important biologic process involved in mod­
ulation of cell populations during deVelopment and differentia­
tion and in elimination of damaged cells to maintain functional 
integrity of many organs [1]. Dysregulation of apoptosis pro­
motes survival of malignant cells. Alteration of apoptosis in the 
immune system is crucial in the development of autoimmunity . 
Apoptosis is also one outcome of immunologic cytotoxicity. Immu­
nologic cytotoxicity is a fundamental mechanism in the immune 
response, produciog selective destruction of cellular targets by hu­
moral or cellular effector mechanisms. Necrosis induced by membrane 
damage and triggeriog of apoptosis are important endpoints of im­
munologic cytotoxicity [2]. Activated cytotoxic T lymphocytes can 
induce apoptosis through binding of a surface ligand to the FAS 
receptor on the target. Apoptosis can also be mediated by cytokines 
released by activated lymphocytes or macrophages such as tumor 
necrosis factor (TNF) and interferon g=a (IFN-)'). Cytotoxic 
lymphocytes activated through the T-cell receptor release perforins 
and granzymes that induce target cell dearl"l through necrosis or 
apoptosis . Thus, cytotoxic T cells can induce both apoptosis and 
necrosis [2]. Other cytotoxic effectors such as activated macrophage 
and lymphokine-activated killers can also produce combinations of 
necrosis induced by perforins and apoptosis induced by cytokine 
release. 
APOPTOSIS IN THE SKIN: ROLE IN EPIDERMIS AND THE 
HAIR FOLLICLE 
Ultrastructural and biochemical analysis has established that apop­
tosis is seen in normal epidermis and in the matrix of cycling hair 
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follicles [3]. Apoptosis can also be identified in aberrant locations in 
diseases such as lichen planus where basal keratinocyte apoptosis 
has been described. The proto-oncogene Bcl-2 is found in the basal 
keratinocyte layer [4], and may act as an inhibitor of basal kerati­
nocyte apoptosis. Stenn and colleagues have recently demonstrated 
in mouse hair follicles th at Bcl-2 expression is maintained in dermal 
papilla cells duriog catagen and telogen, but that Bcl-2 levels 
decrease in the hair bulb , in the bulge and in the outer root sheath 
during catagen and telogen [5]. The implication is that the dermal 
papilla is protected by Bcl-2 from the induction of apoptosis. 
APOPTOSIS OF DERMAL PAPILLA CELLS IN 
ALOPECIA AREATA 
Degenerative changes in dermal papilla cells in the involved scalp 
of alopecia areata [6] indicate that these cells are an important target 
in ills disease . We propose that the peribulbar lymphocytic infil­
trate in AA damages or suppresses the dermal papilla cells leading to 
initiation of catagen and involution of the follicle. One measure of 
immunologic damage to dermal papilla cells would be induction of 
apoptosis by cytokines or by binding to cells surface FAS. 
To test ills hypothesis, we first examined the susceptibility of 
cultured dermal papilla cells from normal donors to the induc tion of 
apoptosis by ionophores, cytokines , or triggering of FAS. As 
indicated in Table I. dermal papilla cells were susceptible to the 
induction of apoptosis by the ionophore beauvericin. but not by any 
of the cytokines or by anti-FAS. For comparison, the keratinocyte 
cell lines HaCaT and KB were susceptible to low-level induction of 
apoptosis by a number of immunologic mediators. Thus cultured 
dermal papilla cells appear to be resistant to the induction of 
apoptosis by immunologic mediators . 
We then examined nine biopsies from alopecia areata patients, 
for morphologic evidence of apoptosis in th e dermal papillae as 
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